Study of Lenalidomide in Combination With AT-101 for Relapsed or Refractory B-cell Chronic Lymphocytic Leukemia

This study is not yet open for participant recruitment.
Verified July 2013 by Mayo Clinic
Sponsor:
Information provided by (Responsible Party):
Asher Alban (Asher) A. Chanan Khan, M.D., Mayo Clinic
ClinicalTrials.gov Identifier:
NCT01003769
First received: October 28, 2009
Last updated: July 9, 2013
Last verified: July 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is not yet open for participant recruitment.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: March 2014 (Final data collection date for primary outcome measure)